Back
Nektar Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58
NKTR
Nektar Therapeutics
Last Price:
$68.11
Seasonality Move:
2.91%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and NKTR is experiencing slight buying pressure.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.41 | Sell |
| 20-day SMA: | 59.93 | Buy |
| 50-day SMA: | 48.17 | Buy |
| 200-day SMA: | 40.37 | Buy |
| 8-day EMA: | 68.46 | Sell |
| 20-day EMA: | 61.99 | Buy |
| 50-day EMA: | 54.28 | Buy |
| 200-day EMA: | 42.61 | Buy |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.2 | Buy |
| Relative Strength Index (14 RSI): | 64.38 | Buy |
| Chaikin Money Flow: | 55297 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.72 - 71.86) | Buy |
| Bollinger Bands (100): | (41.82 - 64.4) | Buy |
Nektar Therapeutics Technical Analysis
| Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | Mar 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 68.36 while NKTR 8-day simple moving average is 70.41, which is a Sell signal.
-
The stock price of NKTR is 68.36 while Nektar Therapeutics 20-day SMA is 59.93, which makes it a Buy.
-
Nektar Therapeutics 50-day simple moving average is 48.17 while NKTR share price is 68.36, making it a Buy technically.
-
NKTR stock price is 68.36 and Nektar Therapeutics 200-day simple moving average is 40.37, creating a Buy signal.
NKTR Technical Analysis vs Fundamental Analysis
Buy
58
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a BuyThe current Nektar Therapeutics [NKTR] share price is $68.36. The Score for NKTR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
1.2B
Price in USD:
68.36
Share Volume:
884.8K
Nektar Therapeutics 52-Week Range
52-Week High:
75.67
52-Week Low:
6.48
Buy
58
Nektar Therapeutics (NKTR)
is a Buy
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 68.36 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is not overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 68.36 while NKTR 8-day exponential moving average is 68.46, which is a Sell signal.
-
The stock price of NKTR is 68.36 while Nektar Therapeutics 20-day EMA is 61.99, which makes it a Buy.
-
Nektar Therapeutics 50-day exponential moving average is 54.28 while NKTR share price is 68.36, making it a Buy technically.
-
NKTR stock price is 68.36 and Nektar Therapeutics 200-day simple moving average is 42.61, creating a Buy signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $2.76 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.36 per share, and a decrease next year of $2.17 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is 7.2, suggesting Nektar Therapeutics is a Buy
-
Nektar Therapeutics Relative Strength Index (RSI) is 64.38, which suggest Nektar Therapeutics is overbought
-
The Bollinger Bands (25) for Nektar Therapeutics is (38.72 - 71.86), which suggest Nektar Therapeutics is a Buy
-
The Bollinger Bands (100) for Nektar Therapeutics is (41.82 - 64.4), which suggest Nektar Therapeutics is a Buy
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.